Chief Financial Officer
United States of America
David Mackney was appointed as Chief Financial Officer on 2 February 2009. Prior to joining Vernalis David worked with Ian as Interim CFO at Acambis plc, working to successfully secure the US biodefence contract, the secondary financing and the acquisition of Acambis by Sanofi-Aventis. Prior to Acambis, David was CFO for a private equity-backed technology company and served as Group Financial Controller at Shire plc. From 1996 to 2001,
David worked as a senior manager in audit and then in transaction services at Arthur Andersen. He is a Chartered Accountant.